Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4520350
Max Phase: Preclinical
Molecular Formula: C52H63N11O7
Molecular Weight: 954.15
Molecule Type: Unknown
Associated Items:
ID: ALA4520350
Max Phase: Preclinical
Molecular Formula: C52H63N11O7
Molecular Weight: 954.15
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=CCN1CC#CC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@H](C(N)=O)CCCC1
Standard InChI: InChI=1S/C52H63N11O7/c1-4-24-63-25-14-12-22-41(46(54)64)58-51(69)43(27-34-16-6-5-7-17-34)61-52(70)45(29-36-31-56-40-21-11-9-19-38(36)40)60-48(66)33(3)57-50(68)44(28-35-30-55-39-20-10-8-18-37(35)39)62-49(67)42(23-13-15-26-63)59-47(65)32(2)53/h4-11,16-21,30-33,41-45,55-56H,1,12,14,22-29,53H2,2-3H3,(H2,54,64)(H,57,68)(H,58,69)(H,59,65)(H,60,66)(H,61,70)(H,62,67)/t32-,33-,41-,42-,43+,44+,45-/m0/s1
Standard InChI Key: VUKCFEZGDZZWBB-FEULRTLSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 954.15 | Molecular Weight (Monoisotopic): 953.4912 | AlogP: 1.50 | #Rotatable Bonds: 11 |
Polar Surface Area: 278.53 | Molecular Species: BASE | HBA: 9 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.66 | CX Basic pKa: 8.62 | CX LogP: 2.21 | CX LogD: 0.34 |
Aromatic Rings: 5 | Heavy Atoms: 70 | QED Weighted: 0.07 | Np Likeness Score: 0.45 |
1. Danelius E, Ohm RG, Ahsanullah, Mulumba M, Ong H, Chemtob S, Erdelyi M, Lubell WD.. (2019) Dynamic Chirality in the Mechanism of Action of Allosteric CD36 Modulators of Macrophage-Driven Inflammation., 62 (24): [PMID:31774287] [10.1021/acs.jmedchem.9b00918] |
2. (2018) Novel cyclic peptides and uses thereof, |
Source(2):